Pirfenidone

Catalog No.S2907 Batch:S290708

Print

Technical Data

Formula

C12H11NO
Molecular Weight 185.22 CAS No. 53179-13-8
Solubility (25°C)* In vitro DMSO 37 mg/mL (199.76 mM)
Ethanol 37 mg/mL (199.76 mM)
Water Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O
1.85mg/ml Taking the 1 mL working solution as an example, add 50 μL of 37 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
Clear solution
5% DMSO 95% Corn oil
1.85mg/ml Taking the 1 mL working solution as an example, add 50 μL of 37 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description Pirfenidone is an inhibitor for TGF-β production and TGF-β stimulated collagen production, reduces production of TNF-α and IL-1β, and also has anti-fibrotic and anti-inflammatory properties. Pirfenidone attenuates chemokine (CC motif) ligand-2 (CCL2) and CCL12 production with anti-fibrotic activity. Phase 3.
Targets
TGF-β [2]
(Cell-free assay)
In vitro

Pirfenidone (< 300 μg/mL) suppresses the proinflammatory cytokine tumor necrosis factor-α (TNF-α) by a translational mechanism in RAW264.7 cells, which is independent of activation of the mitogen-activated protain kinase (MAPK) 2, p38 MAP kinase, and c-Jun N-terminal kinase (JNK). [1]

Pirfenidone (< 10 mM) leads to reduced glioma cell density in concentration-dependent manner in LN-18, T98G, LNT-229 and LN-308 cell lines. Pirfenidone (< 5 mM) reduces TGF-β bioactivity by affecting TGF-β2 mRNA expression and processing of pro-TGF-β in CCL-64 cells. Pirfenidone (< 8.3 mM) inhibits the activity of recombinant furin and downregulates the expression of MMP-11 in a dose-dependent manner in LN-308 cells. [2]
In vivo

Pirfenidone (250 mg/kg) potently inhibits the production of the proinflammatory cytokines, TNF-alpha, interferon-gamma, and interleukin-6, but enhances the production of the anti-inflammatory cytokine, interleukin-10, in mice. [1]

Pirfenidone (250 mg/kg/day) ameliorates cyclosporine-induced fibrosis by about 50% and decreases TGF-beta1 protein expression by 80% in Sprague-Dawley rats receiving a low-salt diet. [3]

Pirfenidone (400 mg/kg/day) inhibits heat shock protein 47-positive cells and myofibroblasts, the principal cells responsible for the accumulation and deposition of extracellular matrix seen in pulmonary fibrosis in ICR mice intravenously injected with bleomycin. [4]

Pirfenidone (0.5%, liquid diet) treatment reduces the degree of liver injury in rats, as determined by alanine aminotransferase values and necro-inflammatory score, which is associated with reduced hepatic stellate cells proliferation and collagen deposition. Pirfenidone (0.5%, liquid diet) administration downregulates dimethylnitrosamine induced transcripts levels of procollagen alpha1(I), TIMP-1 and MMP-2 by 50-60% in rats, and this is associated with a 70% reduction in collagen deposition. [5]

Protocol (from reference)

Cell Assay:

[6]
  • Cell lines

    ACHN cells

  • Concentrations

    0.5 mg/ml

  • Incubation Time

    12 h

  • Method

    Cells were treated with various concentrations of drug.
Animal Study:

[3]
  • Animal Models

    Sprague-Dawley rats receiving a low-salt diet

  • Dosages

    250 mg/kg

  • Administration

    oral diet

Customer Product Validation

Data from [Data independently produced by Histochem Cell Biol, 2014, 142(4), 361-71]

, , Am J Respir Cell Mol Biol, 2017, 57(1):77-90

Data from [Data independently produced by , , Aging Cell, 2018, doi: 10.1111/acel.12788]

Selleck's Pirfenidone has been cited by 52 publications

Repositioning of ezetimibe for the treatment of idiopathic pulmonary fibrosis [ Eur Respir J, 2024, 2300580] PubMed: 38359963
Huaier-induced suppression of cancer-associated fibroblasts confers immunotherapeutic sensitivity in triple-negative breast cancer [ Phytomedicine, 2024, 135:156051] PubMed: 39299097
Aerosol inhalation of total ginsenosides repairs acute lung injury and inhibits pulmonary fibrosis through SMAD2 signaling-mediated mechanism [ Phytomedicine, 2024, 133:155871] PubMed: 39098168
Modulation of Extracellular Matrix Composition and Chronic Inflammation with Pirfenidone Promotes Scar Reduction in Retinal Wound Repair [ Cells, 2024, 13(2)164] PubMed: 38247855
Pirfenidone Prevents Heart Fibrosis during Chronic Chagas Disease Cardiomyopathy [ Int J Mol Sci, 2024, 25(13)7302] PubMed: 39000409
Pirfenidone ameliorates alcohol-induced promotion of breast cancer in mice [ Front Oncol, 2024, 14:1351839] PubMed: 38590657
Functional analysis and validation of oncodrive gene AP3S1 in ovarian cancer through filtering of mutation data from whole-exome sequencing [ Eur J Med Res, 2024, 29(1):231] PubMed: 38609993
Systemic low-dose anti-fibrotic treatment attenuates ovarian aging in the mouse [ bioRxiv, 2024, 2024.06.21.600035] PubMed: 38979191
Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis [ Acta Pharmacol Sin, 2023, 10.1038/s41401-023-01156-w] PubMed: 37696989
Macrophage activity at the site of tumor ablation can promote murine urothelial cancer via transforming growth factor-β1 [ Front Immunol, 2023, 14:1070196] PubMed: 36761730

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.